Preference-Weighted Health Status of PTSD Among Veterans: An Outcome for Cost-Effectiveness Analysis Using Clinical Data

被引:0
|
作者
Freed, Michael C. [1 ,2 ]
Yeager, Derik E. [3 ,4 ]
Liu, Xian [1 ,2 ]
Gore, Kristie L. [1 ,2 ]
Engel, Charles C. [1 ,2 ]
Magruder, Kathryn M. [3 ,4 ]
机构
[1] Walter Reed Army Med Ctr, Deployment Hlth Clin Ctr, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA
[3] Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
关键词
POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; UTILITY MEASURES; METAANALYSIS; SYMPTOMS; PHARMACOTHERAPY; AFGHANISTAN; PREVALENCE; VALIDATION; CHECKLIST;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Posttraumatic stress disorder (PTSD) is a highly prevalent, chronic, disabling but treatable condition. Preference-based measures (for example, health utilities) are recommended for and useful in cost-effectiveness analyses and for policy decisions because they reflect a population's valuation of the desirability of disease states. However, no such measures exist for PTSD. This study aimed to estimate preference-weighted health status associated with PTSD and common co-occurring mental disorders in a sample of veterans by transforming health-related quality-of-life data into preference-weighted health status scores (PWHS scores), develop a usable regression model to predict PWHS scores from other data sets, and compare preference-weighted health status of PTSD with that of another chronic disorder, chronic obstructive pulmonary disease (COPD). Methods: A secondary analysis was performed on data from a random sample of 808 veterans (79% male; 12% met criteria for PTSD) in four primary care clinics. Veterans responded to the PTSD Checklist (PCL), Clinician-Administered PTSD Scale, Mini-International Neuropsychiatric Interview, and Medical Outcomes Survey Short Form-36. Results: PWHS scores were .029 lower among veterans with PTSD compared with veterans without PTSD, all else being equal. However, scores depended on PTSD severity, when the analysis controlled for other model variables. Specifically, PWHS scores dropped by .004 with a 1-unit increase in PCL scores among veterans without PTSD. Among veterans with PTSD, the reduction was .002. PTSD was associated with lower preference-weighted health status than COPD. Conclusions: This is the first study to estimate preference-weighted health status of persons with PTSD. These PWHS scores can be helpful in cost-effectiveness studies of PTSD treatments. (Psychiatric Services 60: 1230-1238, 2009)
引用
收藏
页码:1230 / 1238
页数:9
相关论文
共 50 条
  • [1] TIME PREFERENCE FOR HEALTH IN COST-EFFECTIVENESS ANALYSIS
    LIPSCOMB, J
    MEDICAL CARE, 1989, 27 (03) : S233 - S253
  • [2] Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss
    Ulrikke J. V. Hernæs
    Kjell A. Johansson
    Trygve Ottersen
    Ole F. Norheim
    PharmacoEconomics, 2017, 35 : 965 - 974
  • [3] Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss
    Hernaes, Ulrikke J. V.
    Johansson, Kjell A.
    Ottersen, Trygve
    Norheim, Ole F.
    PHARMACOECONOMICS, 2017, 35 (09) : 965 - 974
  • [4] Bayesian cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    Montmartin, J
    STATISTICS IN MEDICINE, 2001, 20 (05) : 733 - 753
  • [5] A framework for cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    HEALTH ECONOMICS, 2001, 10 (04) : 303 - 315
  • [6] Remote Management of Osteoporosis Screening and Treatment in US Veterans Using a Bone Health Team: A Cost-Effectiveness Analysis
    Miller, Karla L.
    King, Jordan
    Lawrence, Phillip
    Nelson, Richard
    Lafleur, Joanne
    Cannon, Grant
    Nelson, Scott
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] Using Cost-Effectiveness Analysis to Address Health Equity Concerns
    Cookson, Richard
    Mirelman, Andrew J.
    Griffin, Susan
    Asaria, Miqdad
    Dawkins, Bryony
    Norheim, Ole Frithjof
    Verguet, Stephane
    Culyer, Anthony J.
    VALUE IN HEALTH, 2017, 20 (02) : 206 - 212
  • [8] Markov modeling for cost-effectiveness using federated health data network
    Haug, Markus
    Oja, Marek
    Pajusalu, Maarja
    Mooses, Kerli
    Reisberg, Sulev
    Vilo, Jaak
    Gimenez, Antonio Fernandez
    Falconer, Thomas
    Danilovic, Ana
    Maljkovic, Filip
    Dawoud, Dalia
    Kolde, Raivo
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2024, 31 (05) : 1093 - 1101
  • [9] Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges
    Meunier, Aurelie
    Longworth, Louise
    Kowal, Stacey
    Ramagopalan, Sreeram
    Love-Koh, James
    Fin, Susan Grif
    VALUE IN HEALTH, 2023, 26 (01) : 60 - 63
  • [10] On the probability of cost-effectiveness using data from randomized clinical trials
    Willan A.R.
    BMC Medical Research Methodology, 1 (1) : 1 - 5